Skip to main content
Synergus
Home
About
Our Publications
Employment Opportunities
Intern/Thesis Opportunities
Find Us
Privacy Policy
Projects for good
Contact Us
IGES group
Subscribe to Synergus RWE News
Real World Evidence
Real World Data Sources
Real World Data / Statistical analysis
Evidence For Decisions
Market Access
Diagnostics
Digital Health
European Review and Strategy
Evidence Requirements and Outcomes
Evidence Strategy and Development
Reimbursement Application and Hands-On Support
Digital Health Germany
Medical Device
Market access strategy
Market Access Overview
Hands-on market access support
Reimbursement dossier / HTA dossier
Reimbursement/DRG analysis
Countries
HEOR
Health Economics
Cost Effectiveness and Budget Impact Modelling
Economic Outcomes in Clinical Studies
Value Demonstration
Events/Webinars
News
Blog
Home
About
Our Publications
Employment Opportunities
Intern/Thesis Opportunities
Find Us
Privacy Policy
Projects for good
Subscribe to Synergus RWE News
IGES group
Contact Us
Real World Evidence
Real World Data Sources
Real World Data / Statistical analysis
Evidence For Decisions
Market Access
Diagnostics
Digital Health
European Review and Strategy
Evidence Requirements and Outcomes
Evidence Strategy and Development
Reimbursement Application and Hands-On Support
Digital Health Germany
Medical Device
Market access strategy
Market Access Overview
Reimbursement/DRG analysis
Reimbursement dossier / HTA dossier
Hands-on market access support
Countries
HEOR
Health Economics
Cost Effectiveness and Budget Impact Modelling
Economic Outcomes in Clinical Studies
Value Demonstration
Events/Webinars
News
Blog
Blog
Class IIb and III – Clarify Eligibility for 137 (h) prior to submitting NUB in Germany!
17 Sep 2023
Tags:
Germany
Coverage with Evidence Development
read more
France: Temporary reimbursement pending results from clinical trial
18 Jul 2023
Tags:
France
Coverage with Evidence Development
read more
Medical Device and HTA Regulation - Norwegian perspective
09 Jul 2023
Tags:
HTAR
HTAR Medtech
Norway
read more
Coverage With Evidence Development for Digital Health
11 Jun 2023
Tags:
Digital Health
Coverage with Evidence Development
DHS France
DHS Germany
DHS Belgium
read more
France includes organisational benefits in the assessment of Digital solutions
06 Jan 2023
Tags:
Digital Health
DHS France
read more
Teaser about what is possible with Danish RWE studies
05 Jan 2023
Tags:
HQ_RWD_DK
read more
France has the most extensive scope of reimbursement for digital solutions in Europe
28 Dec 2022
Tags:
Digital Health
DHS France
read more
France creates a permanent pathway for remote monitoring solutions
21 Dec 2022
Tags:
Digital Health
DHS France
read more
France launches fast-track process for reimbursement of digital solutions
08 Dec 2022
Tags:
Digital Health
DHS France
read more
Comparing RWD : Finland vs Sweden
31 Oct 2022
Tags:
HQ_RWD_FI
HQ_RWD_SWE
read more
Show More
Contact us
Tags
Alzheimer
Alzheimer Payer Readiness
Artificial Intelligence
China
Co-payment
Corona virus
Country specific
Coverage with Evidence Development
COVID-19
Data Science in Oncology
Dementia
Denmark
DHS Belgium
DHS France
DHS Germany
Diabetes
Digital Health
Digital Heath Strategies
Disease Specific
EMA
Empowered Patients
EQ-5D
Finland
France
Funding
Germany
Health Economics
Heart Failure
HQRWE_Fracture
HQ_RWD_DK
HQ_RWD_FI
HQ_RWD_SWE
HTA
HTAR
HTAR Medtech
Imaging
Innovation Funding
Italy
IVD
Legislation
Lung Cancer
Market Access
Medical Device
Melanoma
Mental Health
Netherlands
Norway
Obesity
Oncology
Out-patient procedures
Patient Registries
Quality of Life
Real World Data
Real World Evidence
RefugeeMD
Registries
Rheumatoid Arthritis
RWD Sources
RWE Sources
SF-36
Stroke
Sweden
The Netherlands
Throat Cancer
Transferability of Outcomes
United Kingdom
Value Based Healthcare
